Accelerating PROTAC Programmes to Drug the ‘Undruggable’
By Syngene InternationalPROteolysis TArgeting Chimeras (PROTACs) have garnered a lot of attention in recent times for their ability to exploit the cell's own degradation machinery to irreversibly degrade target proteins.
In this free white paper, we discuss how Syngene can help you move your PROTAC programmes from hit to lead to the clinic with speed.